Earnings calendar

Revolution Medicines, Inc. (RVMD) earnings: date, estimates, results and stock reactions

Over the last 12 reports the stock moved 4.8% on average (either way), rising 5 times and falling 7. EPS beat estimates 2 of 12 times; revenue 2 of 2. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q4 FY20262026-11-04-1.90-2.35+19.1%197.6M25.6M-8.5%
Q3 FY20262026-08-05-3.06-2.04-50.0%n/a1.8M+2.2%
Q2 FY20262026-05-06-2.29-1.84-24.5%n/a2.4M-3.2%
Q1 FY20262026-02-25-1.86-1.58-17.7%n/a3.7M-2.6%
Q4 FY20252025-11-05-1.61-1.42-13.4%n/a1.7M+4.8%
Q3 FY20252025-08-06-1.31-1.14-15.1%n/a27.5M-9.0%
Q2 FY20252025-05-07-1.13-1.12-0.9%n/a1.2M+11.9%
Q1 FY20252025-02-26-1.12-1.01-10.9%n/a375000-5.5%

RVMD stock report · Earnings calendar